check_circleStudy Completed
Contraception, Menorrhagia, Endometrial Hyperplasia, Estrogen replacement therapy
Bayer Identifier:
14474
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Mirena observational program
Trial purpose
Mirena is used for long-term in Kazakhstan, and in our observational program we would like to study patients distribution per indications of Mirena, and also patient compliance within a year after Mirena insertion. For patients with all approved indications for Mirena use: contraception, treatment of menorrhagia and protection from endometrial hyperplasia during estrogen replacement therapy
Key Participants Requirements
Sex
FemaleAge
18 - N/ATrial summary
Enrollment Goal
2725Trial Dates
May 2009 - November 2015Phase
N/ACould I Receive a placebo
NoProducts
Mirena (Levonorgestrel IUS, BAY86-5028)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many Locations, Kazakhstan |
Primary Outcome
- Patient distribution per indicationdate_rangeTime Frame:12 monthsenhanced_encryptionNoSafety Issue:
Secondary Outcome
- Patient compliancedate_rangeTime Frame:12 monthsenhanced_encryptionNoSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A